[go: up one dir, main page]

FR3092759B1 - Actif pour homogénéiser le teint, notamment des peaux à carnation olive - Google Patents

Actif pour homogénéiser le teint, notamment des peaux à carnation olive Download PDF

Info

Publication number
FR3092759B1
FR3092759B1 FR1901470A FR1901470A FR3092759B1 FR 3092759 B1 FR3092759 B1 FR 3092759B1 FR 1901470 A FR1901470 A FR 1901470A FR 1901470 A FR1901470 A FR 1901470A FR 3092759 B1 FR3092759 B1 FR 3092759B1
Authority
FR
France
Prior art keywords
skin
treatment
complexion
olive
emogenize
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1901470A
Other languages
English (en)
Other versions
FR3092759A1 (fr
Inventor
Caroline Ringenbach
Nathalie Rouyer
Olga Gracioso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sederma SA
Original Assignee
Sederma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sederma SA filed Critical Sederma SA
Priority to FR1901470A priority Critical patent/FR3092759B1/fr
Priority to PCT/EP2020/053800 priority patent/WO2020165365A1/fr
Priority to EP20706163.1A priority patent/EP3923904A1/fr
Publication of FR3092759A1 publication Critical patent/FR3092759A1/fr
Application granted granted Critical
Publication of FR3092759B1 publication Critical patent/FR3092759B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

L’invention propose l’utilisation de cellules végétales indifférenciées ou dédifférenciées, entières et/ou lysées, de Buddleja davidii Franch. obtenues par un procédé de culture cellulaire in-vitro, et/ou d’un extrait intracellulaire desdites cellules débarrassé des débris cellulaires, pour un traitement cosmétique non-thérapeutique topique pour homogénéiser le teint de la peau, via notamment la prévention et/ou le traitement des hétérogénéités pigmentaires et/ou de texture de la peau. Le traitement est particulièrement adapté pour le traitement des peaux de phototype III à V developpant des taches et des zones d’hyperpigmentation, et en particulier encore pour le traitement des peaux à carnation olive.
FR1901470A 2019-02-14 2019-02-14 Actif pour homogénéiser le teint, notamment des peaux à carnation olive Active FR3092759B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1901470A FR3092759B1 (fr) 2019-02-14 2019-02-14 Actif pour homogénéiser le teint, notamment des peaux à carnation olive
PCT/EP2020/053800 WO2020165365A1 (fr) 2019-02-14 2020-02-13 Principe actif pour homogénéiser le teint, en particulier celui des peaux présentant un teint olivâtre
EP20706163.1A EP3923904A1 (fr) 2019-02-14 2020-02-13 Principe actif pour homogénéiser le teint, en particulier celui des peaux présentant un teint olivâtre

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1901470A FR3092759B1 (fr) 2019-02-14 2019-02-14 Actif pour homogénéiser le teint, notamment des peaux à carnation olive
FR1901470 2019-02-14

Publications (2)

Publication Number Publication Date
FR3092759A1 FR3092759A1 (fr) 2020-08-21
FR3092759B1 true FR3092759B1 (fr) 2024-03-08

Family

ID=67262559

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1901470A Active FR3092759B1 (fr) 2019-02-14 2019-02-14 Actif pour homogénéiser le teint, notamment des peaux à carnation olive

Country Status (3)

Country Link
EP (1) EP3923904A1 (fr)
FR (1) FR3092759B1 (fr)
WO (1) WO2020165365A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3117034B1 (fr) * 2020-12-04 2023-04-28 Biospectrum Inc Lysat de cal comprenant une teneur élevée en métabolite de cal et son procédé de préparation
FR3144163A1 (fr) 2022-12-22 2024-06-28 Sederma Procédé d’obtention d’un extrait d’origine végétale, une composition contenant ledit extrait et son utilisation cosmétique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR059545A1 (es) * 2006-02-28 2008-04-09 Bayer Consumer Care Ag Combinacion de verbacosido y luteolina
KR20100028202A (ko) * 2008-09-04 2010-03-12 닥터후 주식회사 밀몽화 추출물을 포함하는 피부미백 활성을 갖는 조성물
EP2260831A1 (fr) * 2009-06-12 2010-12-15 L V M H Recherche Extraits de plantes à modulation Myo-X à utiliser dans des compositions
FR2998570B1 (fr) 2012-11-26 2016-12-02 Sederma Sa Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes
FR3021319B1 (fr) 2014-05-22 2018-08-31 Sederma Peptides, compositions les comprenant et utilisations notamment cosmetiques

Also Published As

Publication number Publication date
EP3923904A1 (fr) 2021-12-22
WO2020165365A1 (fr) 2020-08-20
FR3092759A1 (fr) 2020-08-21

Similar Documents

Publication Publication Date Title
Shi et al. Premature graying as a consequence of compromised antioxidant activity in hair bulb melanocytes and their precursors
Chen et al. Light-emitting diode 585 nm photomodulation inhibiting melanin synthesis and inducing autophagy in human melanocytes
FR3092759B1 (fr) Actif pour homogénéiser le teint, notamment des peaux à carnation olive
Itoh et al. Inhibitory effects of Citrus hassaku extract and its flavanone glycosides on melanogenesis
CY1112327T1 (el) Θεραπευτικοι ρετροϊικοι φορεις για γονιδιακη θεραπεια
Choi et al. Exposure of human melanocytes to UVB twice and subsequent incubation leads to cellular senescence and senescence-associated pigmentation through the prolonged p53 expression
Lv et al. Protective roles of mesenchymal stem cells on skin photoaging: A narrative review
KR100848056B1 (ko) 줄기세포 배양액을 이용한 멜라닌 합성저해 방법
ATE489935T1 (de) Verwendung von glycyrrhetinsäure und/oder glycyrrhizin zur herstellung von zubereitungen zur bräunung der haut
KR101494375B1 (ko) 피부 또는 헤어의 색소침착 연구 또는 조절에 유용한 방법, 화장 관리 방법 및 조성물용 식물 추출물
Wang et al. Ginsenoside Rb1 inhibits matrix metalloproteinase 13 through down-regulating Notch signaling pathway in osteoarthritis
JP6223960B2 (ja) 細胞外マトリックスの組織化に関連した皮膚色素斑の分子シグネチャー
Zhai et al. Effects of UV induced-photoaging on the hair follicle cycle of C57BL6/J mice
Zhang et al. Uncovering key mechanisms and intervention therapies in aging skin
CN112469819B (zh) 化妆品组合物以及用于制备神经干细胞条件培养基的方法
Jing et al. Oat β‐glucan repairs the epidermal barrier by upregulating the levels of epidermal differentiation, cell–cell junctions and lipids via Dectin‐1
EP3634375B1 (fr) Potentiel anti-âge de métabolite extracellulaire isolé debacillus coagulans mtcc 5856
Hashmi et al. Clinicopathological features of alopecia with an emphasis on etiology and histopathological characteristics of scarring alopecia
US12194038B2 (en) Use of flibanserin in preparation of drug for treating androgenic alopecia
CN107028782B (zh) 异甘草素或异甘草苷在制备高安全性的抗衰老化妆品中的用途
Shinozaki et al. Expression analysis of genes important for maintaining skin function in a senescence‐accelerated mouse prone model
KR102178778B1 (ko) 피부줄기세포 배양액을 포함하는 피부 노화 예방 또는 개선용 조성물 및 이의 용도
Shin et al. Anti-melanogenic effect of lotus seed and seedpod extracts via downregulation of tyrosinase stability in B16F10 murine melanoma cells
KR20240036068A (ko) 피부 장애 및 병태를 예방 또는 치료하는 방법
Sperling et al. Central centrifugal cicatricial alopecia: A common but under‐recognized and under‐treated disease finally comes of age.

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200821

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7